Although ADAM9 has been shown to enhance pulmonary vascular remodeling in lung cancer via VEGFA, angiopoietin-2, and tissue plasminogen activator [19, 36], there is a paucity of literature linking ADAM9 to PH. The gene discussed is ADAM9; the disease is lung carcinoma.